查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317792

吸入治疗市场雾化器：按类型、用途和最终用户划分 - 全球预测 2023-2030

Inhalation Therapy Nebulizer Market by Type, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年，全球吸入治疗雾化器市场将达到 23.9868 亿美元，年复合成长率为 7.77%，预计到 2030 年将出现惊人增长，达到 40.5663 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球吸入治疗雾化器市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 吸入治疗雾化器的全球市场规模与预测为何？

2.在预测期内，COVID-19 影响全球吸入治疗雾化器市场的阻碍因素与影响有哪些？

3. 在预测期内，全球吸入治疗雾化器市场需要投资哪些产品/细分市场/应用/领域？

4.全球吸入治疗雾化器市场的竞争策略为何？

5. 全球吸入治疗雾化器市场的技术趋势和法律规范是什么？

6.全球吸入治疗雾化器市场主要供应商的市占率为何？

7. 哪些型态和策略措施被认为适合进入吸入治疗雾化器全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 慢性呼吸道疾病盛行率上升
      • 需要家庭健康设备
      • 患有各种疾病的老年人口不断增加
    • 抑制因素
      • 吸入治疗雾化器对健康的副作用
    • 机会
      • 使用雾化器吸入治疗其他类型的疾病，例如糖尿病
      • 透过支持性卫生政策提高对吸入治疗雾化器的认识
    • 任务
      • 单一有效吸入装置的可用性降低
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章吸入治疗市场雾化器：依类型

  • 雾化器喷射
  • 超音波雾化器

第7章吸入治疗雾化器市场：依用途

  • 气喘
  • 慢性阻塞性肺病
  • 囊性纤维化
  • 鼻塞

第8章吸入治疗雾化器市场：依最终用户分类

  • 门诊手术中心
  • 居家护理中心
  • 医院

第9章美洲吸入治疗雾化器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太吸入治疗雾化器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲吸入治疗雾化器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-43127F727986

The Global Inhalation Therapy Nebulizer Market is forecasted to grow significantly, with a projected USD 2,398.68 million in 2023 at a CAGR of 7.77% and expected to reach a staggering USD 4,056.63 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Inhalation Therapy Nebulizer Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Inhalation Therapy Nebulizer Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Atomizer Jet and Ultrasonic Nebulizers. The Atomizer Jet is projected to witness significant market share during forecast period.

Based on Application, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Nasal Congestion. The Nasal Congestion is projected to witness significant market share during forecast period.

Based on End User, market is studied across Ambulatory Surgery Centers, Home Care Centers, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Inhalation Therapy Nebulizer Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Inhalation Therapy Nebulizer Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Inhalation Therapy Nebulizer Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Inhalation Therapy Nebulizer Market?

4. What is the competitive strategic window for opportunities in the Global Inhalation Therapy Nebulizer Market?

5. What are the technology trends and regulatory frameworks in the Global Inhalation Therapy Nebulizer Market?

6. What is the market share of the leading vendors in the Global Inhalation Therapy Nebulizer Market?

7. What modes and strategic moves are considered suitable for entering the Global Inhalation Therapy Nebulizer Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Inhalation Therapy Nebulizer Market, by Type, 2022 vs 2030
  • 4.3. Inhalation Therapy Nebulizer Market, by Application, 2022 vs 2030
  • 4.4. Inhalation Therapy Nebulizer Market, by End User, 2022 vs 2030
  • 4.5. Inhalation Therapy Nebulizer Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of chronic respiratory diseases
      • 5.1.1.2. Need for home healthcare devices
      • 5.1.1.3. Increasing geriatric population with various disease
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of inhalation therapy nebulizer on the health
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of inhalation therapy nebulizer in other kinds of diseases such as diabetes
      • 5.1.3.2. Increasing awareness about the inhalation therapy nebulizer with supportive health policies
    • 5.1.4. Challenges
      • 5.1.4.1. Less availability of single effective inhaler devices
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Inhalation Therapy Nebulizer Market, by Type

  • 6.1. Introduction
  • 6.2. Atomizer Jet
  • 6.3. Ultrasonic Nebulizers

7. Inhalation Therapy Nebulizer Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease
  • 7.4. Cystic Fibrosis
  • 7.5. Nasal Congestion

8. Inhalation Therapy Nebulizer Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Centers
  • 8.4. Hospitals

9. Americas Inhalation Therapy Nebulizer Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalation Therapy Nebulizer Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalation Therapy Nebulizer Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INHALATION THERAPY NEBULIZER MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION THERAPY NEBULIZER MARKET SIZE, 2022 VS 2030
  • FIGURE 3. INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. INHALATION THERAPY NEBULIZER MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. INHALATION THERAPY NEBULIZER MARKET DYNAMICS
  • FIGURE 9. INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. INHALATION THERAPY NEBULIZER MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. INHALATION THERAPY NEBULIZER MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. INHALATION THERAPY NEBULIZER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. INHALATION THERAPY NEBULIZER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. INHALATION THERAPY NEBULIZER MARKET SIZE, BY ATOMIZER JET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION THERAPY NEBULIZER MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. INHALATION THERAPY NEBULIZER MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INHALATION THERAPY NEBULIZER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INHALATION THERAPY NEBULIZER MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INHALATION THERAPY NEBULIZER MARKET SIZE, BY NASAL CONGESTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. INHALATION THERAPY NEBULIZER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOME CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INHALATION THERAPY NEBULIZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INHALATION THERAPY NEBULIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. INHALATION THERAPY NEBULIZER MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. INHALATION THERAPY NEBULIZER MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. INHALATION THERAPY NEBULIZER MARKET LICENSE & PRICING